NUTRIBAND INC. news, videos and press releases
For more news please use our advanced search feature.
NUTRIBAND INC. - More news...
NUTRIBAND INC. - More news...
- Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
- UPDATE – Nutriband Signs Associate Partnership with Charlotte FC
- Nutriband Signs Partnership Agreement with Charlotte FC
- Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
- Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
- Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
- Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
- Nutriband Issues Letter to Shareholders
- Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
- Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
- Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
- Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
- Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
- Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
- Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
- Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year
- Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30
- Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
- Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
- Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
- Nutriband Inc. Announces $8.4M Private Placement
- Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance
- Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
- Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting
- Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting
- Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st
- Nutriband CEO Publishes Letter to Shareholders
- Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
- Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling
- Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape
